Sepracor settles patent suit with Teva

NEW YORK - Sepracor Inc. said yesterday that it will allow Teva Pharmaceutical Industries Ltd. to launch generic versions of its respiratory drug Xopenex in 2013 under terms of a patent lawsuit settlement.